[1] Drilon A, De Braud FG, Siena S, Ou SHI, Patel M, Ahn MJ, Lee J, Bauer TM, et al. Entrectinib, an oral pan-Trk, ROS1, and ALK inhibitor in TKI-na?ve patients with advanced solid tumors harboring gene rearrangements – updated phase I results.Presentation Session: Clinical Trials Plenary Session, Sunday, April 17, 4:15-6 p.m. CT, La Nouvelle Orleans Ballroom. AACR 2016 Abstract CT007
Home Drilon A, De Braud FG, Siena S
